Eisai
4523.T
$44.30
Share price
0.25%
Change (1 day)
-26.57%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Eisai (4523.T) - P/B ratio
P/B ratio as of May 2024 : 2.13
According to Eisai's latest financial reports the company has a price-to-book ratio of 2.13.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Eisai - P/B ratio (from 2009 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.40 | -21.71% |
| 2022-12-31 | 3.06 | 24.17% |
| 2021-12-31 | 2.47 | -18.56% |
| 2020-12-31 | 3.03 | -13.74% |
| 2019-12-31 | 3.51 | -9.9% |
| 2018-12-31 | 3.90 | 30.01% |
| 2017-12-31 | 3.00 | -4.88% |
| 2016-12-31 | 3.15 | -17.77% |
| 2015-12-31 | 3.83 | 69.93% |
| 2014-12-31 | 2.26 | -1.29% |
| 2013-12-31 | 2.29 | -4.2% |
| 2012-12-31 | 2.39 | 3.93% |
| 2011-12-31 | 2.30 | 10.42% |
| 2010-12-31 | 2.08 | -7.82% |
| 2009-12-31 | 2.26 |